Cutaneous malignant melanoma in the Swedish organ transplantation cohort: A study of clinicopathological characteristics and mortality

Journal of the American Academy of Dermatology

Volumn 73, Issue 1, 2015, Pages 106-113.e2

  Krynitz, Britta ^a   Rozell, Barbro Lundh ^b   Lyth, Johan ^b,c   Smedby, Karin E ^d   Lindelöf, Bernt ^a,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

histopathology; immunosuppression; melanocytic nevi; melanoma; melanoma specific mortality; population based study; posttransplantation; Swedish Melanoma Register

Indexed keywords

ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CLINICAL ARTICLE; CUTANEOUS MELANOMA; FEMALE; GRAFT RECIPIENT; HAZARD RATIO; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MALIGNANT LENTIGO; MORTALITY; ORGAN TRANSPLANTATION; PIGMENTED NEVUS; PRIORITY JOURNAL; SWEDEN; ADULT; AGED; COHORT ANALYSIS; MELANOMA; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS;

ADULT; AGED; COHORT STUDIES; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; SWEDEN;

EID: 84937967876     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2015.03.045     Document Type: Article

References (31)

1. E. Dahlke, C.A. Murray, J. Kitchen, and A.W. Chan Systematic review of melanoma incidence and prognosis in solid organ transplant recipients Transplantation Res 3 2014 10
2. C.S. Hollenbeak, M.M. Todd, E.M. Billingsley, G. Harper, A.M. Dyer, and E.J. Lengerich Increased incidence of melanoma in renal transplantation recipients Cancer 104 2005 1962 1967
3. B. Krynitz, G. Edgren, B. Lindelöf, and et al. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008-a Swedish population-based study Int J Cancer 132 2013 1429 1438
4. C.M. Vajdic, M.T. van Leeuwen, A.C. Webster, and et al. Cutaneous melanoma is related to immune suppression in kidney transplant recipients Cancer Epidemiol Biomarkers Prev 18 2009 2297 2303
5. A.W. Kubica, and J.D. Brewer Melanoma in immunosuppressed patients Mayo Clin Proc 87 2012 991 1003
6. Y. Miao, J.J. Everly, T.G. Gross, and et al. De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population Transplantation 87 2009 1347 1359
7. C.M. Vajdic, A.H. Chong, P.J. Kelly, and et al. Survival after cutaneous melanoma in kidney transplant recipients: a population-based matched cohort study Am J Transplant 14 2014 1368 1375
8. F.O. Zwald, L.J. Christenson, E.M. Billingsley, and et al. Melanoma in solid organ transplant recipients Am J Transplant 10 2010 1297 1304
9. M.H. Greene, T.I. Young, and W.H. Clark Jr. Malignant melanoma in renal-transplant recipients Lancet 1 1981 1196 1199
10. L. Le Mire, K. Hollowood, D. Gray, C. Bordea, and F. Wojnarowska Melanomas in renal transplant recipients Br J Dermatol 154 2006 472 477
11. R.N. Matin, D. Mesher, C.M. Proby, and et al. Melanoma in organ transplant recipients: clinicopathological features and outcome in 100 cases Am J Transplant 8 2008 1891 1900
12. J.D. Brewer, L.J. Christenson, A.L. Weaver, and et al. Malignant melanoma in solid transplant recipients: collection of database cases and comparison with surveillance, epidemiology, and end results data for outcome analysis Arch Dermatol 147 2011 790 796
13. J.F. Ludvigsson, P. Otterblad-Olausson, B.U. Pettersson, and A. Ekbom The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research Eur J Epidemiol 24 2009 659 667
14. C. Lindholm, R. Andersson, M. Dufmats, and et al. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors Cancer 101 2004 2067 2078
15. C.M. Balch, A.C. Buzaid, S.J. Soong, and et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma J Clin Oncol 19 2001 3635 3648
16. H. Eriksson Clinical and epidemiological studies on prognostic and predictive factors in cutaneous melanoma institution for oncology and pathology, Ph. D. Thesis, ISBN 978-91-7549-252-0 2013 Karolinska Institutet Stockholm, Sweden
17. National Board of Health and Welfare CfE. Dödsorsakstatistik-Historik, produktionsmetoder och tillförlitlighet. Komplement till reporten Dödsorsaker 2008. In Swedish, 2010. Available at: http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/18019/2010-4-33.pdf. Accessed February 16, 2015.
18. C.M. Balch, J.E. Gershenwald, S.J. Soong, and et al. Final version of 2009 AJCC melanoma staging and classification J Clin Oncol 27 2009 6199 6206
19. E. Calonje, T. Brenn, T. Lazar, and P. McKee Pathology of the skin 4th ed. 2011 Elsevier Saunders Philadelphia, PA
20. R. King Lentiginous melanoma Arch Pathol Lab Med 135 2011 337 341
21. H. Kutzner, G. Metzler, Z. Argenyi, and et al. Histological and genetic evidence for a variant of superficial spreading melanoma composed predominantly of large nests Mod Pathol 25 2012 838 845
22. W.H. Clark Jr., D.E. Elder, D. Guerry, and et al. Model predicting survival in stage I melanoma based on tumor progression J Natl Cancer Inst 81 1989 1893 1904
23. R. Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 1141 1154
24. C. Bevona, W. Goggins, T. Quinn, J. Fullerton, and H. Tsao Cutaneous melanomas associated with nevi Arch Dermatol 139 2003 1620 1624 discussion 24
25. S. Kaddu, J. Smolle, P. Zenahlik, R. Hofmann-Wellenhof, and H. Kerl Melanoma with benign melanocytic naevus components: reappraisal of clinicopathological features and prognosis Melanoma Res 12 2002 271 278
26. C.G. Clemente, M.C. Mihm Jr., R. Bufalino, S. Zurrida, P. Collini, and N. Cascinelli Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma Cancer 77 1996 1303 1310
27. M. Guba, C. Graeb, K.W. Jauch, and E.K. Geissler Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation Transplantation 77 2004 1777 1782
28. C.H. Smith, J.M. McGregor, J.N. Barker, R.W. Morris, S.P. Rigden, and D.M. MacDonald Excess melanocytic nevi in children with renal allografts J Am Acad Dermatol 28 1993 51 55
29. J. Szepietowski, F. Wasik, T. Szepietowski, M. Wlodarczyk, K. Sobczak-Radwan, and W. Czyz Excess benign melanocytic nevi in renal transplant recipients Dermatology 194 1997 17 19
30. S. Piaserico, M. Alaibac, A.B. Fortina, and A. Peserico Clinical and dermatoscopic fading of post-transplant eruptive melanocytic nevi after suspension of immunosuppressive therapy J Am Acad Dermatol 54 2006 338 340
31. E. Zattra, A.B. Fortina, M. Bordignon, S. Piaserico, and M. Alaibac Immunosuppression and melanocyte proliferation Melanoma Res 19 2009 63 68